Synthio Labs Launches DOSE Benchmark: Leading Voice AI Models Mispronounce Up to One in Three Newly Approved Drug Names

Nine commercial text-to-speech systems tested on 274 medicines in clinical sentences; ElevenLabs, Google, Deepgram, Microsoft and OpenAI models drop sharply on recently approved drugs SAN FRANCISCO, Sept. 17, 2026 /PRNewswire/ -- Synthio Labs, a clinical-grade voice and agentic AI company for pharma, today published DOSE (Drug-name Oral Synthesis Evaluation), the first public benchmark of how accurately text-to-speech (TTS) systems pronounce drug names. DOSE tests nine models on 274 drug names, 146 of them newly approved, each read inside a real clinical sentence. Read the full report here.